According to GuruFocus Insider Data, the recent CFO sells were for Regeneron Pharmaceuticals Inc. (REGN, Financial), Zoetis Inc. (ZTS, Financial) and Zoom Video Communications Inc. (ZM, Financial).
Regeneron Pharmaceuticals Inc. Executive Vice President Finance CFO Robert E. Landry sold 414 shares
Executive Vice President Finance CFO Robert E. Landry sold 414 shares for $452.49 per share on Feb. 26. Since then, the stock price has increased by 2.89%.
Regeneron Pharmaceuticals Inc. has a market cap of $51.22 billion and its shares were traded around $465.55. The company has a price-earnings ratio of 25.22 and price-sales ratio of 6.77. Over the past five years, Regeneron Pharmaceuticals Inc had an annual average earnings growth of 26.80%.
Regeneron Pharmaceuticals announced its fourth-quarter results with revenue of $2.17 billion and gross profit of $1.95 billion, while the net income was $792 million. The gross profit was $6.28 billion, a 15% increase from the year prior. The net income was $2.44 billion.
President and Chief Scientific Officer George Yancopoulos sold 117,815 shares for $470.47 per share on March 10. Since then, the stock price has decreased by 1.05%.
10% Owner Sanofi sold 128,914 shares for $489.65 per share on March 9. Since then, the stock price has decreased by 4.92%.
Director Joseph L. Goldstein sold 2,000 shares for $475.84 per share on March 9. Since then, the stock price has decreased by 2.16%.
Zoetis Inc. CFO Glenn David sold 43,778 shares
CFO Glenn David sold 43,778 shares for $140.89 per share on March 5. Since then, the stock price has decreased by 10.94%.
Zoetis Inc. has a market cap of $59.59 billion and its shares were traded around $125.48. The company has a price-earnings ratio of 40.20 and price-sales ratio of 9.66. The trailing 12-month dividend yield of Zoetis Inc. stocks is 0.54%, while the forward dividend yield is 0.67%. Over the past 10 years, Zoetis Inc. had an annual average earnings growth of 53.30%. GuruFocus rated Zoetis Inc. the business predictability rank of 2.5-star.
Zoetis Inc. announced its fourth-quarter results with revenue of $1.67 billion and gross profit of $1.14 billion, while the net income was $384 million. The 2019 total revenue was $6.26 billion, a 7% increase from 2018. The gross profit was $4.27 billion, a 9% increase from the year prior. The net income was $1.50 billion.
CEO Kristin C. Peck sold 11,925 shares for $138.1 per share on Feb. 25. Since then, the stock price has decreased by 9.14%.
Director Juan Ramon Alaix sold 263,660 shares for $141.26 per share on March 4. Since then, the stock price has decreased by 11.17%.
Executive Vice President Heidi C. Chen sold 1,179 shares for $134.3 per share on March 2. Since then, the stock price has decreased by 6.57%.
Zoom Video Communications Inc. CFO Kelly Steckelberg sold 11,067 shares
CFO Kelly Steckelberg sold 11,067 shares for $102.66 per share on Feb. 19. Since then, the stock price has increased by 4.69%.
Zoom Video Communications Inc. has a market cap of $29.7 billion and its shares were traded around $107.47. The company has a price-earnings ratio of 1074.70 and price-sales ratio of 41.25.
Zoom Video Communications announced its first-quarter results with revenue of $188.25 million and gross profit of $155.70 million, while the net income was $15.34 million. The 2019 total revenue was $622.66 million, an 88% increase from 2018. The gross profit was $507.26 million, an 88% increase from the year prior. The net income was $25.31 million.
CEO, 10% Owner Eric S. Yuan sold 140,286 shares for $89.17 per share on Feb. 13. Since then, the stock price has increased by 20.52%.
Director Santiago Subotovsky sold 73,168 shares for $108.63 per share on March 10. Since then, the stock price has decreased by 1.07%.
Chief Marketing Officer Janine Pelosi sold 31,850 shares for $107.92 per share on March 9. Since then, the stock price has decreased by 0.42%.
Disclosure: none
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here
